HALO Award Disclosure
Connaughton Bernadette · SEC Form 4 · Filed Oct 8, 2026
Award
Calculated transaction value
$0
Connaughton Bernadette Director
HALO
Transaction date
May 5, 2026
Public filing date
Oct 8, 2026
Filing lag
Filed 156 days later
HALO daily price context
Close on/before transaction
$65.87
May 5, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,796 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4/A
- Filing identifier
- 0001159036-26-000139
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Halozyme Therapeutics, Inc. HALO Current | Award | May 5, 2026 | $0 |